GSILX | RERBX | GSILX / RERBX | |
Total Expense Ratio | 1.88 | 1.56 | 121% |
Annual Report Gross Expense Ratio | 1.91 | 1.56 | 122% |
Fund Existence | 9 years | 23 years | - |
Gain YTD | 15.552 | 15.438 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 54.3B | 135B | 40% |
Annual Yield % from dividends | 1.07 | 0.25 | 420% |
Returns for 1 year | -1.57 | 7.07 | -22% |
Returns for 3 years | 37.00 | 21.86 | 169% |
Returns for 5 years | 44.35 | 8.46 | 524% |
Returns for 10 years | N/A | 25.90 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CRSH | 4.12 | 0.07 | +1.73% |
YieldMax Short TSLA Option Income Strategy ETF | |||
VHT | 252.54 | 3.93 | +1.58% |
Vanguard Health Care ETF | |||
ENOR | 27.75 | 0.12 | +0.43% |
iShares MSCI Norway ETF | |||
TAXX | 50.81 | 0.01 | +0.03% |
BondBloxx IR+M Tax-Awr Shrt Dur ETF | |||
CDC | 65.56 | -0.22 | -0.33% |
VictoryShares US EQ Inc Enh Vol Wtd ETF |